Henan Lingrui Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Henan Lingrui Pharmaceutical has a total shareholder equity of CN¥2.9B and total debt of CN¥12.5M, which brings its debt-to-equity ratio to 0.4%. Its total assets and total liabilities are CN¥4.9B and CN¥2.0B respectively. Henan Lingrui Pharmaceutical's EBIT is CN¥709.0M making its interest coverage ratio -11.2. It has cash and short-term investments of CN¥956.8M.
Key information
0.4%
Debt to equity ratio
CN¥12.53m
Debt
| Interest coverage ratio | -11.2x |
| Cash | CN¥956.81m |
| Equity | CN¥2.90b |
| Total liabilities | CN¥1.98b |
| Total assets | CN¥4.89b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600285's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥1.9B).
Long Term Liabilities: 600285's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥66.0M).
Debt to Equity History and Analysis
Debt Level: 600285 has more cash than its total debt.
Reducing Debt: 600285's debt to equity ratio has reduced from 9% to 0.4% over the past 5 years.
Debt Coverage: 600285's debt is well covered by operating cash flow (5226.3%).
Interest Coverage: 600285 earns more interest than it pays, so coverage of interest payments is not a concern.